Organon reports new findings from Vtama atopic dermatitis trials

Data ReadoutVtama cream, 1%Neutral

AI Analysis

Summary

Organon reported data from a post hoc analysis of pooled data from its Phase III ADORING 1 and ADORING 2 trials evaluating Vtama cream 1% for atopic dermatitis. The article provides limited information regarding specific findings or outcomes from the analysis.

Clinical Trial Data

Phase

Phase III

Outcome Details

Post hoc analysis of pooled data from Phase III ADORING 1 and ADORING 2 trials

Importance:4/10

Sentiment:

0.00

atopic dermatitisVtamaPhase IIIpost hoc analysis

Related Companies

$TRAX $ARNA

Read the original article

Published by Clinical Trials Arena on July 27, 2026 10:24 AM

Read Original